Gulack Brian C, Yang Chi-Fu Jeffrey, Speicher Paul J, Yerokun Babatunde A, Tong Betty C, Onaitis Mark W, D'Amico Thomas A, Harpole David H, Hartwig Matthew G, Berry Mark F
Department of Surgery, Duke University Medical Center, Durham, North Carolina.
Department of Cardiothoracic Surgery, Stanford University Medical Center, Stanford, California.
Ann Thorac Surg. 2016 Dec;102(6):1814-1820. doi: 10.1016/j.athoracsur.2016.06.032. Epub 2016 Sep 1.
The long-term survival benefit of lobectomy over sublobar resection for early-stage non-small cell lung cancer must be weighed against a potentially increased risk of perioperative mortality. The objective of the current study was to create a risk score to identify patients with favorable short-term outcomes following lobectomy.
The 2005-2012 American College of Surgeons National Surgical Quality Improvement Program database was queried for patients undergoing a lobectomy or sublobar resection (either segmentectomy or wedge resection) for lung cancer. A multivariable logistic regression model was utilized to determine factors associated with 30-day mortality among the lobectomy group and to develop an associated risk score to predict perioperative mortality.
Of the 5,749 patients who met study criteria, 4,424 (77%) underwent lobectomy, 1,098 (19%) underwent wedge resection, and 227 (4%) underwent segmentectomy. Age, chronic obstructive pulmonary disease, previous cerebrovascular event, functional status, recent smoking status, and surgical approach (minimally invasive versus open) were utilized to develop the risk score. Patients with a risk score of 5 or lower had no significant difference in perioperative mortality by surgical procedure. Patients with a risk score greater than 5 had significantly higher perioperative mortality after lobectomy (4.9%) as compared to segmentectomy (3.6%) or wedge resection (0.8%, p < 0.01).
In this study, we have developed a risk model that predicts relative operative mortality from a sublobar resection as compared to a lobectomy. Among patients with a risk score of 5 or less, lobectomy confers no additional perioperative risk over sublobar resection.
对于早期非小细胞肺癌,肺叶切除术相对于肺段以下切除术的长期生存获益必须与围手术期死亡风险可能增加相权衡。本研究的目的是创建一个风险评分,以识别肺叶切除术后短期预后良好的患者。
查询2005 - 2012年美国外科医师学会国家外科质量改进计划数据库中接受肺癌肺叶切除术或肺段以下切除术(肺段切除术或楔形切除术)的患者。采用多变量逻辑回归模型确定肺叶切除组中与30天死亡率相关的因素,并制定相关风险评分以预测围手术期死亡率。
在符合研究标准的5749例患者中,4424例(77%)接受了肺叶切除术,1098例(19%)接受了楔形切除术,227例(4%)接受了肺段切除术。利用年龄、慢性阻塞性肺疾病、既往脑血管事件、功能状态、近期吸烟状态和手术方式(微创与开放)来制定风险评分。风险评分为5或更低的患者,不同手术方式的围手术期死亡率无显著差异。风险评分大于5的患者,肺叶切除术后围手术期死亡率(4.9%)显著高于肺段切除术(3.6%)或楔形切除术(0.8%,p < 0.01)。
在本研究中,我们开发了一种风险模型,可预测与肺叶切除术相比肺段以下切除术的相对手术死亡率。在风险评分为5或更低的患者中,肺叶切除术与肺段以下切除术相比,围手术期无额外风险。